LL-37

LL-37 is the only cathelicidin-family antimicrobial peptide expressed in humans and a principal subject of innate-immunity research. Laboratory work characterizes it as both a membrane-active effector against microbes and a multifunctional signaling molecule. Investigators study how it influences inflammation, immune-cell recruitment, and tissue-repair pathways in controlled in-vitro systems. Material is provided solely for laboratory research use.

Research models examine LL-37’s amphipathic structure, which enables insertion into microbial lipid bilayers, pore formation, and loss of membrane integrity. Parallel studies map its interactions with host receptors that modulate cytokine release, chemotaxis, and angiogenic signaling. Concentration is a critical variable: lower levels are frequently associated with protective or homeostatic signals, while higher levels can drive pro-inflammatory responses in cell-culture assays. These dual actions are dissected using purified peptide in defined experimental conditions.

In-vitro investigations focus on direct antimicrobial activity against bacteria, fungi, and selected viruses. Additional research streams explore immunomodulation, leukocyte chemotaxis, and endothelial-cell responses relevant to wound-healing models. Scientists also probe peptide interactions with epithelial and immune-cell surfaces to identify downstream pathways. Concentration-dependent protective versus inflammatory outcomes remain a central experimental theme.

Cell-based and membrane-mimetic assays have documented LL-37-mediated permeabilization of microbial membranes and growth inhibition of diverse pathogens. Parallel work has recorded its capacity to recruit immune cells and alter cytokine profiles in culture. Wound-healing models have shown effects on endothelial migration and vessel-formation pathways. Across these systems, experimental results consistently highlight that peptide concentration strongly influences the balance between antimicrobial and pro-inflammatory readouts.

LL-37 is typically supplied as a lyophilized solid that requires sterile reconstitution for membrane, cell-culture, or biochemical assays. Laboratory protocols emphasize protection from repeated freeze-thaw cycles and proteolytic degradation to preserve activity. Investigators select buffer conditions and working concentrations appropriate to the specific in-vitro model under study. All handling remains restricted to non-clinical research environments.